Crosslink Capital
No summary available yet.
Crosslink is the steady, reliable choice for B2B companies that want smart money without the drama. They're not flashy or trendy - they won't be tweeting about your round or putting you on stage at conferences. What they will do is actually help you think through pricing, customer segmentation, and scaling sales. Their portfolio performance speaks for itself with multiple IPOs and acquisitions. The downside? They can be pretty conservative and process-heavy, so if you're looking for someone to take big swings with you or move at startup speed, look elsewhere.
- —Best for: B2B SaaS companies ready to scale with proven product-market fit
- —Known for: Solid operational support and strong track record of successful exits
- —Watch out for: Conservative approach may not suit companies needing aggressive growth capital
Crosslink Capital focuses on growth-stage technology companies, particularly in B2B software, fintech, and healthcare technology. They target companies with proven business models that need capital to scale operations and expand market reach.
Series A through growth stage, typically $5-50M checks. Heavy focus on B2B SaaS, fintech, healthcare IT, and enterprise software. Portfolio skews toward proven revenue companies rather than early-stage bets.
Former Goldman Sachs investment banker turned VC with deep enterprise software experience. Known for his analytical approach and strong network in the B2B space. Founders appreciate his direct communication style.
Previously at Matrix Partners and Oracle, brings operational experience from the enterprise software trenches. Reputation for being hands-on with portfolio companies on go-to-market strategy.
Former McKinsey consultant and enterprise software executive. Known for his strategic thinking and ability to help companies navigate complex market dynamics and scaling challenges.
Have a specific question about Crosslink Capital?
Ask Bernie →